To determine whether supplementation with the long-chain omega-@ polyunsaturated fatty acids eicosapentaenoic ( EPA ) and docosahexaenoic acid ( DHA ) affects behavioral symptoms and cognitive impairments in children @-@ years of age diagnosed with attention-deficit/hyperactivity disorder ( ADHD ) .